153 related articles for article (PubMed ID: 29340062)
21. Swedish Version of the Distress Thermometer: Validity Evidence in Patients With Colorectal Cancer.
Sarenmalm EK; Nasic S; Håkanson C; Öhlén J; Carlsson E; Pettersson ME; Sawatzky R
J Natl Compr Canc Netw; 2018 Aug; 16(8):959-966. PubMed ID: 30099372
[No Abstract] [Full Text] [Related]
22. Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire.
Skarstein J; Aass N; Fosså SD; Skovlund E; Dahl AA
J Psychosom Res; 2000 Jul; 49(1):27-34. PubMed ID: 11053601
[TBL] [Abstract][Full Text] [Related]
23. Comparison of EORTC quality of life core questionnaire (EORTC-QLQ-C30) and gastrointestinal quality of life index (GIQLI) in patients undergoing elective colorectal cancer resection.
Schwenk W; Neudecker J; Haase O; Raue W; Strohm T; Müller JM
Int J Colorectal Dis; 2004 Nov; 19(6):554-60. PubMed ID: 15205989
[TBL] [Abstract][Full Text] [Related]
24. Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30.
Chiu L; Chiu N; Zeng L; Zhang L; Popovic M; Chow R; Lam H; Poon M; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):831-7. PubMed ID: 23252363
[TBL] [Abstract][Full Text] [Related]
25. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the psychological burden during the early disease trajectory in patients with intracranial tumors by the ultra-brief Patient Health Questionnaire for Depression and Anxiety (PHQ-4).
Renovanz M; Soebianto S; Tsakmaklis H; Keric N; Nadji-Ohl M; Beutel M; Ringel F; Wollschläger D; Hickmann AK
Support Care Cancer; 2019 Dec; 27(12):4469-4477. PubMed ID: 30904948
[TBL] [Abstract][Full Text] [Related]
27. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran.
Khoshnevisan A; Yekaninejad MS; Ardakani SK; Pakpour AH; Mardani A; Aaronson NK
Health Qual Life Outcomes; 2012 May; 10():54. PubMed ID: 22607028
[TBL] [Abstract][Full Text] [Related]
28. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore.
Tan ML; Idris DB; Teo LW; Loh SY; Seow GC; Chia YY; Tin AS
Asia Pac J Oncol Nurs; 2014; 1(1):22-32. PubMed ID: 27981079
[TBL] [Abstract][Full Text] [Related]
29. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
30. Anxiety, depression and quality of life in colorectal cancer patients.
Tsunoda A; Nakao K; Hiratsuka K; Yasuda N; Shibusawa M; Kusano M
Int J Clin Oncol; 2005 Dec; 10(6):411-7. PubMed ID: 16369745
[TBL] [Abstract][Full Text] [Related]
31. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
33. The Basic Documentation for Psycho-Oncology Short Form (PO-Bado SF)--an expert rating scale for distress screening: development and psychometric properties.
Marten-Mittag B; Book K; Buchhold B; Dinkel A; Gründobler B; Henrich G; Huber B; Pirker C; Regenberg A; Schickel S; Senf B; Wünsch A; Herschbach P
Psychooncology; 2015 Jun; 24(6):653-60. PubMed ID: 25346529
[TBL] [Abstract][Full Text] [Related]
34. Screening for psychological distress in follow-up care to identify head and neck cancer patients with untreated distress.
Krebber AM; Jansen F; Cuijpers P; Leemans CR; Verdonck-de Leeuw IM
Support Care Cancer; 2016 Jun; 24(6):2541-8. PubMed ID: 26694718
[TBL] [Abstract][Full Text] [Related]
35. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.
Gadisa DA; Gebremariam ET; Ali GY
Health Qual Life Outcomes; 2019 Dec; 17(1):182. PubMed ID: 31830992
[TBL] [Abstract][Full Text] [Related]
36. Screening for psychological distress in two French cancer centers: feasibility and performance of the adapted distress thermometer.
Dolbeault S; Bredart A; Mignot V; Hardy P; Gauvain-Piquard A; Mandereau L; Asselain B; Medioni J
Palliat Support Care; 2008 Jun; 6(2):107-17. PubMed ID: 18501045
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of a nurse-led intervention with the distress thermometer for patients treated with curative intent for breast cancer: design of a randomized controlled trial.
Ploos van Amstel FK; Prins JB; van der Graaf WT; Peters ME; Ottevanger PB
BMC Cancer; 2016 Jul; 16():520. PubMed ID: 27455960
[TBL] [Abstract][Full Text] [Related]
38. The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review.
Leung A; Lien K; Zeng L; Nguyen J; Caissie A; Culleton S; Holden L; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):693-700. PubMed ID: 22098285
[TBL] [Abstract][Full Text] [Related]
39. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
[TBL] [Abstract][Full Text] [Related]
40. Psychometric properties of the EORTC QLQ-C30 in Uganda.
Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
